Mandatory training for Medicare SNP providers
Dec. 2023Important Notices
The Centers for Medicare and Medicaid Services (CMS) require all Medicare Special Needs Plan (SNP) providers to complete the Model of Care (MOC) Training every year. The MOC describes the structure and process by which health care services are delivered to SNP members.
For your convenience, UPMC Health Plan has developed a brief online training module on the MOC for our SNP product, UPMC for Life Complete Care (HMO-SNP) (formerly known as UPMC for Life Dual).
To complete the training, go to upmchp.us/snpmoc You will need your tax identification number to sign in and need to attest to completing the training.
Please note that this training must be completed by Feb. 29, 2024.
If you have any questions or concerns, feel free to contact your physician account executive or call Provider Services at 1-866-918-1595.
Thank you for your continued support and the care you provide for our members!
For your convenience, UPMC Health Plan has developed a brief online training module on the MOC for our SNP product, UPMC for Life Complete Care (HMO-SNP) (formerly known as UPMC for Life Dual).
To complete the training, go to upmchp.us/snpmoc You will need your tax identification number to sign in and need to attest to completing the training.
Please note that this training must be completed by Feb. 29, 2024.
If you have any questions or concerns, feel free to contact your physician account executive or call Provider Services at 1-866-918-1595.
Thank you for your continued support and the care you provide for our members!
Recent Announcements
Medicaid Renewal
Starting in 2027, some Medicaid recipients (ages 19–-64) will have new requirements to keep their coverage.Aug. 2026Important Notices
Provider Directory Updates and Required Attestation
As you know, UPMC Health Plan requires all providers to verify their provider directory information at least every 90 days (quarterly).Aug. 2026Important Notices
Voluntary nationwide recall: Tyenne (Fresenius – August 2026)
Fresenius Kabi is recalling one lot, lot 16UI07, of Tyenne® (tocilizumab-aazg) Injection 400 mg/20 mL (20 mg/mL) 20 mL vials. Tyenne is used for the treatment of certain arthritis conditions.Aug. 2026Pharmacy Updates